SCHEMBL20936263

SCHEMBL20936263

C=CCn1c(SCC(=O)Nc2sc3c(c2C(N)=O)CCC3)nnc1C1CCCCC1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 6/20 0.58
GAA P10253 2/20 0.58
CYP3A4 P08684 1/20 0.58
CYP2C9 P11712 1/20 0.58
ALDH1A1 P00352 9/20 0.57
TSHR P16473 7/20 0.57
POLB P06746 7/20 0.56
HSD17B10 Q99714 4/20 0.56
HPGD P15428 4/20 0.56
MAPT P10636 4/20 0.56
ALOX15 P16050 3/20 0.56
KDM4E B2RXH2 3/20 0.56
TDP1 Q9NUW8 2/20 0.56
MEN1 O00255 2/20 0.56
KMT2A Q03164 2/20 0.56
PTPN7 P35236 2/20 0.56
MCL1 Q07820 2/20 0.56
L3MBTL1 Q9Y468 2/20 0.56
RECQL P46063 1/20 0.56
BLM P54132 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21045517 0.95 POLB (0.58) SMN1; SMN2GAACYP3A4CYP2C9ALDH1A1
SCHEMBL21082569 0.93 SMN1; SMN2 (0.59) SMN1; SMN2GAACYP3A4CYP2C9ALDH1A1
SCHEMBL21045253 0.85 ALDH1A1 (0.62) SMN1; SMN2GAACYP3A4CYP2C9ALDH1A1
SCHEMBL21045558 0.84 ALDH1A1 (0.60) SMN1; SMN2GAACYP3A4CYP2C9ALDH1A1
SCHEMBL21045544 0.81 ALDH1A1 (0.74) SMN1; SMN2GAACYP2C9ALDH1A1TSHR
SCHEMBL20936235 0.81 ALDH1A1 (0.65) SMN1; SMN2GAACYP3A4CYP2C9ALDH1A1
SCHEMBL26740038 0.80 ALDH1A1 (0.64) SMN1; SMN2GAAALDH1A1TSHRPOLB
SCHEMBL21045364 0.80 ALDH1A1 (0.63) SMN1; SMN2GAACYP3A4CYP2C9ALDH1A1
SCHEMBL21045565 0.79 ALDH1A1 (0.58) SMN1; SMN2GAAALDH1A1TSHRPOLB
SCHEMBL20936265 0.78 ALDH1A1 (0.70) SMN1; SMN2GAACYP3A4CYP2C9ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11813268-B2 Mitofusin activators and uses thereof ALBERT EINSTEIN COLLEGE OF MEDICINE (US) 2023-11-14 US disclosed
US-11813268-B2 Mitofusin activators and uses thereof ALBERT EINSTEIN COLLEGE OF MEDICINE (US) 2023-11-14 US disclosed
US-11760733-B2 Small molecule regulators of mitochondrial fusion and methods of use thereof WASHINGTON UNIVERSITY (US) 2023-09-19 US disclosed
US-11760733-B2 Small molecule regulators of mitochondrial fusion and methods of use thereof WASHINGTON UNIVERSITY (US) 2023-09-19 US disclosed
US-11760733-B2 Small molecule regulators of mitochondrial fusion and methods of use thereof WASHINGTON UNIVERSITY (US) 2023-09-19 US disclosed
US-10844023-B2 Small molecule regulators of mitochondrial fusion and methods of use thereof WASHINGTON UNIVERSITY (US) 2020-11-24 US disclosed
US-10844023-B2 Small molecule regulators of mitochondrial fusion and methods of use thereof WASHINGTON UNIVERSITY (US) 2020-11-24 US disclosed
US-20200281899-A1 SMALL MOLECULE REGULATORS OF MITOCHONDRIAL FUSION AND METHODS OF USE THEREOF WASHINGTON UNIVERSITY 2020-09-10 US disclosed
US-20200281899-A1 SMALL MOLECULE REGULATORS OF MITOCHONDRIAL FUSION AND METHODS OF USE THEREOF WASHINGTON UNIVERSITY 2020-09-10 US disclosed
US-20190169138-A1 SMALL MOLECULE REGULATORS OF MITOCHONDRIAL FUSION AND METHODS OF USE THEREOF WASHINGTON UNIVERSITY 2019-06-06 US disclosed
US-20190169138-A1 SMALL MOLECULE REGULATORS OF MITOCHONDRIAL FUSION AND METHODS OF USE THEREOF WASHINGTON UNIVERSITY 2019-06-06 US disclosed
WO-2019079243-A1 MITOFUSIN ACTIVATORS AND USES THEREOF ALBERT EINSTEIN COLLEGE OF MEDICINE, INC. (US) 2019-04-25 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190169138-A1 SMALL MOLECULE REGULATORS OF MITOCHONDRIAL FUSION AND METHODS OF USE THEREOF MFN2, FIS1, RHOT2 SMN1; SMN2 365/4885GAA 1388/4885CYP3A4 4535/4885
US-11760733-B2 Small molecule regulators of mitochondrial fusion and methods of use thereof MFN2, FIS1, RHOT2 SMN1; SMN2 365/4885GAA 1388/4885CYP3A4 4535/4885
US-11813268-B2 Mitofusin activators and uses thereof MFN2, TFB2M, PCK2 SMN1; SMN2 507/4885GAA 275/4885CYP3A4 4205/4885
US-20200281899-A1 SMALL MOLECULE REGULATORS OF MITOCHONDRIAL FUSION AND METHODS OF USE THEREOF MFN2, FIS1, RHOT2 SMN1; SMN2 365/4885GAA 1388/4885CYP3A4 4535/4885
US-10844023-B2 Small molecule regulators of mitochondrial fusion and methods of use thereof MFN2, FIS1, RHOT2 SMN1; SMN2 365/4885GAA 1388/4885CYP3A4 4535/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.